KI-7
促销价¥{{model.attbuying.price}}
市场价¥0.00
累计销量0 累计评价0 人评论
-
{{item.title}}
| 包装规格: | 1mg 5mg 10mg 25mg 50mg 100mg in glass bottle |
| 产品描述: | 基本信息 产品编号: K10113 产品名称: KI-7 CAS: 1489263-00-4 储存条件 粉末 -20℃ 四年 分子式: C23H18N2O2 溶于液体 -80℃ 6个月 分子量: 354.40 -20℃ 1个月 化学名: N-Phenyl-2-(1-benzyl-1H-indole-3-yl)-2-oxoacetamide Solubility (25°C): 体外: DMSO Ethanol 'mg/mL Water 体内(现配现用): <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 制备储备液 浓度 溶液体积 质量 1mg 5mg 10mg 1mM 2.8217mL 14.1084mL 28.2167mL 5mM 0.5643mL 2.8217mL 5.6433mL 10mM 0.2822mL 1.4108mL 2.8217mL 生物活性 产品描述 一种 A2B 腺苷受体阳性变构调节剂。KI-7 增强非选择性 A2B 腺苷受体激动剂 NECA 诱导的 cAMP 积累 (EC50=445.8nM)。 靶点 Adenosine Receptor 体外研究 KI-7 (1μM;5-21 days;mesenchymal stem cells) induces a significant increase in mRNA expression of Runx2 and Osterix.KI-7 (1μM;15-21 days) induced a significant increase in cell viability in both differentiation stages.KI-7,as A2B adenosine receptor positive allosteric modulator in MSCs,demonstrating it is able to potentiate the effects of either adenosine and synthetic orthosteric A2B adenosine receptor agonists in mediating osteoblast differentiation in vitro.NECA,BAY 60-6583 and KI-7 induce a strong increase in IL-6 production.KI-7 is able to potentiate the effects of orthosteric agonists in both differentiation stages,even if the effect became significant only at 21 days. |
| 保存条件: | -20℃ |
-
蜀牛玻璃三角瓶
¥85.00 销量:16
-
15mL锥底离心管,袋装灭菌,橙色盖
¥636.00 销量:12
-
UFC5030BK 超滤管[0.5ml 30KD]
¥52.00 销量:10
-
UFC5010BK 超滤管[0.5ml 10KD]
¥52.00 销量:10
-
20×TBST缓冲液
¥130.00 销量:10
-
10mL移液管,易撕型全塑包装
¥456.00 销量:10
-
¥158.00
通用型 DNA 纯化回收试剂盒 -
¥158.00
质粒快速小提试剂盒 -
¥828.00
100mm TC细胞培养皿,袋装灭菌

